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Differential gene expression in two established initiation
and promotion skin carcinogenesis models during promo-
tion and tumor formation was determined by microarray
technology with the purpose of distinguishing the genes
more associated with neoplastic transformation from those
linked with proliferation and differentiation. The first
model utilized dimethylbenz[a]anthracene initiation and
12-O-tetradecanoylphorbol 13-acetate (TPA) promotion
in the FVB/N mouse, and the second TPA promotion of
the Tg.Ac mouse, which is endogenously initiated by virtue
of an activated Ha-ras transgene. Comparison of gene
expression profiles across the two models identified genes
whose altered expression was associated with papilloma
formation rather than TPA-induced proliferation and
differentiation. DMBA suppressed TPA-induced dif-
ferentiation which allowed identification of those genes
associated more specifically with differentiation rather
than proliferation. EASE (Expression Analysis Systemic
Explorer) indicated a correlation between muscle-
associated genes and skin differentiation, whereas genes
involved with protein biosynthesis were strongly correlated
with proliferation. For verification the altered expression of
selected genes were confirmed by RT–PCR; Carbonic
anhydrase 2, Thioredoxin 1 and Glutathione S-transferase
omega 1 associated with papilloma formation and Enolase
3, Cystatin b and Filaggrin associated with TPA-induced
proliferation and differentiation. In situ analysis located
the papillomas Glutathione S-transferase omega 1 expres-
sion to the proliferating areas of the papillomas. Thus we
have identified profiles of differential gene expression
associated with the tumorigenesis and promotion stages
for skin carcinogenesis in the mouse.
Introduction
Murine models of skin carcinogenesis require an activating
mutagenic event followed by multiple applications of an
agent that induces clonal expansion (promotion) of the mutated
cells to form tumors. Two mouse models were utilized that are
widely used to study the molecular mechanisms of initiation
and promotion in skin carcinogenesis. In the first, a single dose
of carcinogen is followed by multiple doses of a promoting
agent (1,2). In the second model, the Tg.Ac mouse carries an
activated Ha-ras transgene, and requires only promotion
to form papillomas (3). The papillomas that develop in both
models are histopathologically similar. The phorbol ester 12-
O-tetradecanoylphorbol 13-acetate (TPA) acts as an efficient
promoting agent in these models by inducing homogeneous
proliferation and differentiation of mouse skin cells, some of
which are the progenitors for papillomas (3–5). Cells that are
not initiated proliferate and differentiate when affected by
TPA but upon TPA withdrawal do not progress to unregulated
division (3,6). There is therefore a pathologically distinct
phase of proliferation and differentiation prior to the formation
of papillomas (3). This response to promotion results in the
differential expression of many genes within the initiated
cells prior to papilloma formation (7,8). It is not clear
whether these alterations are necessary for the formation of
papillomas or associated with proliferation and differentia-
tion only.
Microarray technology has greatly facilitated the study of
differential gene expression and allowed large-scale deter-
mination of gene expression changes associated with tissue
changes and tumor formation. In the skin, microarrays have
previously been used to study the basal gene expression of
mouse strains that are sensitive or resistant to skin carcinogen-
esis (9), and to examine differential gene expressions
associated with the effects of UV irradiation on keratinocyte
wounding (10). Several studies have examined genes differen-
tially expressed in C57BL/6 and NMRI mouse skin in response
to a single dose of TPA and in isolated cells from Tg.Ac mice
treated with multiple doses of TPA (7,8,11,12). The purpose
of this study was to characterize differential gene expression
in murine skin carcinogenesis models by comparing FVB/N
and Tg.Ac mouse skin prior to, and after, the formation of
papillomas. For the classic initiator and promoter protocol
using dimethylbenz[a]anthracene (DMBA) initiation and
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TPA promotion (13) FVB/N mice were chosen as these have
the same genetic background as Tg.Ac mice. Tg.Ac mice
require only promotion with TPA. Further analysis was applied
to classify whether gene changes were associated with either
the tumor formation or the hyperproliferative and differenti-
ation response to promotion by TPA. By comparing common
gene expression changes in the two models of skin carcino-
genesis we sought to demonstrate the association of these
genes with tumor formation in the skin.
Materials and methods
Animals
Female FVB/N and Tg.Ac (hemizygotes) mice 3–5 weeks of age were
purchased from Harlan UK and Taconic UK, respectively. The mice were
contained in an isolator and maintained at 19C with 50% relative humidity
and a 12-h light–dark cycle. Following a 1 week acclimatization period the
dorsal skin of the mice was shaved using clippers (approximately 8 cm2 area)
2 days prior to commencing topical treatments. FVB/N mice (five per group)
were treated with DMBA (10 mg/200 ml in acetone) or vehicle control 1 week
before promotion with TPA. FVB/N and Tg.Ac mice (five per group) were
treated with TPA (2.5 mg/200 ml in acetone) twice a week for up to 14 weeks;
control mice received acetone. All chemicals were applied topically using a
pipette. Mice were shaved and examined weekly for the presence of papillo-
mas. At each time point the mice were killed by cervical dislocation and the
dorsal skin removed, a representative portion was fixed in 10% neutral buffered
formalin for 1 week and processed conventionally, sectioned and stained with
haematoxylin and eosin. The remainder of the tissue was snap frozen in liquid
nitrogen.
Proliferation measured by PCNA immunohistochemistry
Mouse skin sections (5 mm) were cut, dewaxed and taken to water. Antigen
retrieval was performed by microwaving at 700 W for 20 min in 0.01 M citrate
pH 6. The primary antibody to Proliferating Cell Nuclear Antigen (Novocastra,
Newcastle upon Tyne, UK, NCL-PCNA) was used at a dilution of 1:100
and applied to the sections for 3 h at room temperature. Serial control sections
were treated similarly, with the primary antibody replaced by negative control
mouse IgG2a (DAKO, Cambridgeshire, UK X0943). The primary antibody
was detected using a peroxidase-labelled anti-IgG2a antibody (Serotec,
Oxford, UK, STAR82P). The peroxidase was detected using 3,3-diaminoben-
zidine tetrahydrochloride, with the sections lightly counterstained with hae-
matoxylin. The number of cells staining positive for PCNA were counted in
five different fields for each section. The average number of stained cells per
field was calculated for each treatment. Statistical significance was calculated
using a two-tailed unpaired Student’s t-test.
RNA extraction
Approximately 500 mg of tissue was homogenized on ice in Tri reagent (2 ml)
using an Ultraturrax blender and chloroform/isopropanol extraction was
performed twice. During the second round of extraction an extra chloroform
extraction step was added to ensure the RNA was free from lipophilic
contaminants.
Microarrays
To construct the cDNA microarrays, Expressed Sequence Tag (EST) clones
were obtained from the IMAGE collection (MRC Geneservice, Cambridge,
UK) and amplified by PCR. The DNA was printed in betaine (14) onto poly-L-
lysine coated slides. Prior to use the slides were baked for 2 h at 80C, washed
in two changes of 0.2% SDS and two changes of water before being denatured
by baking at 100C for 2 min. Labelling and hybridization reactions were
carried out as previously described (15) except that Microcon YM30 columns
(Millipore, Massachusetts, USA) were used to purify the final reaction products
and the slides were prehybridized as previously described (16). In some experi-
ments repeat hybridizations were carried out with reversal of the fluorescent
dyes. Where the amount of RNA was limiting, 5 mg of RNA was labelled using
Genisphere 3DNA array 350 labelling kits (InterVascular, Cedex, France)
following the manufacturer’s instructions. After hybridization for at least 16 h
at 42C in a 50% formamide buffer the slides were washed as described by (15)
and the fluorescence was measured using GenePix version 3.0 software (Axon
Instruments, CA, USA). Microarray data are available on Arrayexpress (http://
www.ebi.ac.uk/arrayexpress/) using the accession numbers E-MEXP-188,
A-MEXP-98, A-MEXP-99, A-MEXP-100 and A-MEXP-101.
Samples were hybridized to microarrays as follows: (i) TPA-treated only
(T) against DMBA/TPA (DT) with the purpose to identify tumor-associated
genes. This comparison was designed to cancel out any effect of proliferation,
differentiation or TPA exposure; (ii) DMBA only (D) against
DMBA/TPA (DT) to identify those genes both tumor, proliferation- and
differentiation-associated; and (iii) Tg.Ac control against Tg.Ac TPA-treated.
This combination was designed to confirm the data obtained from the FVB/N
DT mice in a different model with a different initiation protocol.
Normalization and statistical analysis
Median pixel–fluorescent intensity data from each array feature were collected
and the local background was subtracted prior to analysis. Data were normal-
ized by a global normalization procedure. Background was not subtracted as
this had been established to have a detrimental effect on the data (Zhang and
Gant, personal communication). Fluorescence data from each array feature
were retained in the data set if positive with respect to the background.
A threshold cut-off was not used except where there existed fluorescent
data in only one channel. These data were retained in the data set if the intensity
of fluorescence in the single channel was greater than 40% of the mean channel
value. After normalization, the ratio of hybridization between the control and
treated samples (where there existed fluorescent values for both channels) was
calculated and statistical analysis of the results performed according to the
methods described by (17). All genes that were significantly altered (P  0.05)
in expression in at least one sample of the time course were clustered using
hierarchical clustering (Cluster 3, University of Tokyo, Human Genome
Centre). EASE (Expression Analysis Systemic Explorer) analysis was per-
formed using bootstrapping with 10 000 iterations on the individual gene
sets associated with the pathological changes (18).
Real time–PCR (RT–PCR)
RNA (400 ng) was reverse-transcribed using Superscript II (Invitrogen,
Paisley, UK) and the resulting cDNA was used for amplification with
SYBR green mastermix (Applied Biosystems, Warrington, UK). Reactions
were carried out on an ABI PRISM 7700 RT–PCR machine using optimized
primers. Primers for RT–PCR were designed using Primer Express software
v2.0 (Applied Biosystems, Warrington, UK). The sequences used were: Car2:
forward, CAAGCACAACGGACCAGAGAA, reverse, GGGCAGTTGCTGT-
GTCAATGT; Cryab: forward CGGAGGAACTCAAAGTCAAGGT, reverse
ATCCGGTACTTCCTGTGGAACTC; Cstb: forward, CCGTGCTACCC-
CGACTACTG, reverse, CAAACTTCTGATTTTCTTTCGATTCA; Eno3:
forward, GCTCCGTGACGGAGTCCAT, reverse, AGCGGTGGCTCACC-
ATCA; Flg: forward, AACACTGAGCAAAGAAGAGCTGAA, reverse,
CAGCGAAATCTAGTTTGTCATCGT; Gsto1, forward, CAGCGACTGGA-
AGCATTGG, reverse, CCGCCATCCAGAGCTTGA; Txn1, forward, TTCC-
TTGAAGTGGACGTGGAT, reverse, CTCACCTTTTGACCCCTTTTTAT-
AA and Inv, forward, GAGCGTGAAGGTTATCAAGGA, reverse, TGCT-
GCTGCTTCTCTGTAGTG. The expression level of the gene of interest
was normalized to that of Cyclophilin A in all samples. Statistical significance
of the data was assessed by two-tailed t-test assuming unequal variance.
In situ hybridization
A plasmid containing a Gsto1 (Accession number AV006756) insert was used
to make a single stranded RNA probe labelled with biotin by incorporation of
biotin-16-UTP (Roche, Penzberg, Germany). The reactions were purified using
Microcon YM30 columns (Millipore, MA, USA) and alkaline digested with
an equal volume of 100 mM sodium carbonate pH 10.2 for 71 min at 60C.
Following digestion, probes were neutralized with an equal volume of 0.2 mM
sodium acetate, 1% glacial acetic acid (v/v), 10 mM dithiothreitol and
precipitated overnight with sodium acetate and ethanol at 20C.
An ELF 97mRNA In Situ Hybridization kit (Invitrogen, Paisley, UK) was
used to detect expression in paraffin-embedded skin sections (4 mm)
on 3-aminopropyltriethoxysilane (APES)-coated slides. The manufacturer’s
instructions were followed for section preparation prior to, and after hybrid-
ization of the probe (10 ng), or no probe negative control. Prehybridization and
hybridization conditions were as described for microarray experiments.
Fluorescence was visualized using an Axioskop fluorescence microscope
(Zeiss, Germany) and pictures were taken using a ProgRes C14 camera
(Jenoptik, Jena, Germany).
Results
Papilloma formation and pathology
Papillomas were induced in DMBA-initiated FVB/N mice
and Tg.Ac mice when promoted with TPA (Figure 1A).
Both strains developed papillomas by 8 weeks after the
commencement of promotion and all FVB/N mice were termi-
nated by 14 weeks due to high papilloma burden. Papilloma
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development occurred much faster in Tg.Ac mice and with a
higher multiplicity leading to their termination after 9 weeks of
promotion. Papillomas only formed in FVB/N mice that were
both initiated and promoted (Figure 1A) as expected. Despite
the altered latency and tumor burden very similar well-
differentiated tumors were generated in both strains of mice.
Due to the difference in papilloma latency time between the
Tg.Ac and FVB/N, mice skin was isolated at different times in
the two strains prior to the formation of papillomas. The time
points were compared with each other by reference to papil-
loma formation rather than by absolute time from the com-
mencement of promotion. Therefore, the Tg.Ac and FVB/N
skin isolated 4 days and 2 weeks, respectively after commen-
cing promotion were comparable in terms of length of time
prior to papilloma formation. This was also true for Tg.Ac
mice skin isolated after 1, 2 and 9 weeks and FVB/N skin
isolated after 4, 6 and 14 weeks of promotion. The timescale
of the sample collection for FVB/N is shown in Figure 1B and
for Tg.Ac in Figure 1C. The histopathological changes in the
skin over the time period can be seen in Figure 2. Mice treated
with TPA showed a proliferative response demonstrated by
an increase in epidermal thickness (Figure 2B to D) and an
increase in the number of cells stained positive for PCNA
(Figure 2L). The increase in the layers of flattened cells
(arrows) containing keratohyaline granules in these skins
also suggested a differentiation response to TPA (Figure 2B
inset). The proliferative response to TPA was greater at
2 weeks in those mice initiated with DMBA prior to TPA
treatment compared with TPA treatment alone, and similar
at both 4 and 6 weeks (Figure 2L). Though proliferation
was greater in the mice initiated with DMBA prior to
TPA treatment, than in TPA alone, at 2 weeks the extent of
differentiation was not as marked (Figure 2E inset). This
DMBA mediated decrease in differentiation response to
TPA was confirmed by Involucrin (Figure 2M) and Filaggrin
(Figure 3B) expression which are both markers of keratinocyte
terminal differentiation (19,20). Expression of these genes
was reduced in the skin of mice initiated with DMBA prior
to TPA treatment compared with those that received TPA
alone. The TPA-only treated Tg.Ac and FVB/N mice showed
similar proliferation responses (Figure 2I to K and Figure B to
D). This was also true at the 14 (FVBN) and 9 week (Tg.Ac)
time points when papillomas were present (Figure 2L).
Genomic analysis
In non-transgenic mice TPA treatment without prior initiation
induced proliferation and differentiation, but did not lead to
papilloma formation (Figure 1 and 2). Therefore, a microarray
analysis of FVB/N mouse skin that had been initiated with
DMBA and promoted with TPA would be complicated by gene
expression effects caused either by the TPA directly or by the
proliferative and differentiation response in the keratinocytes.
To identify these changes two different microarray com-
parisons were made using FVB/N mouse skin. In the first
comparison TPA-promoted skin (T) was compared with
DMBA-initiated and TPA-promoted skin (DT). This compar-
ison was designed to cancel out the effects of TPA exposure
and so reveal those genes more closely associated with tumor
formation. In fact as illustrated in Figure 2 the comparison
cannot be absolute as DMBA had the effect of reducing the
differentiating response of keratinocytes to TPA determined by
Filaggrin (Figure 3B) and Involucrin (Figure 2M) expression.
The second comparison was made between DMBA-initiated
skin (D) and skin that was both DMBA-initiated and TPA-
promoted (DT). This comparison generated a mixed response
where gene expression changes could be associated with tumor
formation, proliferation, differentiation or TPA exposure. For
further discernment of gene designation, comparison was also
made with the Tg.Ac experiment, where the gene expression
responses to differentiation and tumorigenesis should be sim-
ilar to FVB/Nmice. In addition, in this experiment, we took a 4
day sample where direct responses to TPA may be more pro-
nounced.
Genes were chosen for inclusion in Figure 3 if there was at
least one time point where a gene showed a differential expres-
sion with a significance of P  0.05. In total this gave
617 genes for multivariate analysis. The significance criterion
used is relatively low with a potentially larger than desirable
false positive rate. However, because of the nature of the
experimental comparison this was the optimal method for
selecting the genes to go forward for analysis. After selection
of the genes various methods of grouping were tried including
self-organizing maps and principal components analysis. How-
ever, in common with many analyses of this nature, hierarch-
ical clustering with complete linkage was found to yield the
Fig. 1. Tumor latency and sample collection for FVB/N and Tg.Ac mice.
FVB/N mice were initiated with DMBA (10 mg) 1 week prior to
commencing TPA treatment. (A) Both FVB/N (rectangles) and Tg.Ac mice
(diamonds) were treated with TPA (2.5 mg) twice weekly. Papillomas were
counted at weekly intervals, five mice per strain and results are means ±
SEM. (B) Following initiation of FVB/N mice at –1 week promotion began
at week 0 and continued twice weekly for up to 14 weeks. Mouse skin was
analysed for gene expression after 2, 4, 6 and 14 weeks of TPA treatment
which corresponded to time points 1, 2, 3 and 4, respectively. (C)
Promotion of Tg.Ac mice began at 0 weeks and continued twice weekly
for up to 9 weeks. Mouse skin was analysed for changes in gene
expression after 0.57, 1, 2 and 9 weeks of TPA promotion which
corresponded to time points 1, 2, 3 and 4, respectively.
K.Ridd et al.
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Fig. 2. Pathological responses to promotion and initiation and promotion in mouse skin. (A) Normal FVB/N mouse skin; (B) after 2 weeks; (C) 4 weeks;
and (D) 6 weeks TPA promotion. Arrow and insert show differentiated, keratohyaline-containing cells. (E)–(G) are the pathological responses to DMBA
initiation and subsequent TPA promotion at the same time points as (B)–(D), respectively. (H) Normal Tg.Ac skin and then at (I) 4 days, (J) 1 week and
(K) 2 weeks promotion with TPA. (L) FVB/N mouse skin sections were stained with an antibody for PCNA. The number of PCNA positive epidermal cells
was counted in five separate fields for each section with five different sections per designated treatment and time point. Means ± SD, t-tests were carried out
between control and treated skin P  0.05,  P 0.01. (M) RT–PCR analysis of Involucrin expression to confirm the altered differentiation with prior
DMBA(D) treatment in response to TPA(T). Light grey, D/DT; dark grey D/T; P  0.05 for differences between D/DT and D/T as indicated on
the figure.
Gene expression associated with murine skin tumors
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Fig. 3. Cluster analysis of promotion and tumor-associated gene expression. FVB/N mice were treated with DMBA (10 mg) 1 week prior to commencing
TPA or acetone vehicle control treatment (DT or D, respectively). Control FVB/N mice that received acetone instead of DMBA were also treated with TPA
(T). Tg.Ac mice were treated with TPA or acetone vehicle control for the indicated times. Microarray comparisons were carried out between FVB/N D/DT
and T/DT. Tg.Ac sample comparisons were made between acetone and TPA-treated skins, indicated just as Tg.Ac. All genes that were significantly altered
(P  0.05) in expression in at least one sample were clustered using hierarchical clustering (GeneCluster 3.0). The central panel shows a treeview
visualization (either MapleTree (0.2.3.2 Beta or treeview 1.5 (http://rana.lbl.gov/EisenSoftware.htm). The highest density of colour is associated with a
4-fold (log2=2) or more differential regulation, mauve is upregulated and blue downregulated with respect to the ratio as shown in the header or in the case
of Tg.Ac animals it is the TPA-treated over the control (acetone-treated). Clusters associated with differentiation, associated as described in the text, are
shown in panels A–D with those primarily downregulated in response to differentiation in panels A and C, and those upregulated in panels B and D.
Differential gene expression associated more with tumor and tumor formation, associated as described in the text, is shown in panels E–K.
Panels E, F and I are genes increased in expression in response to tumor formation and those in panels G, H and J are downregulated. Panel K shows genes
biochemically associated with increased translation in response to the tumor process. Gene symbols are associated with names in Table II.
K.Ridd et al.
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most interpretable data. The clustering of the whole 617 genes
is shown in Figure 3 and from this individual clusters were
selected based on the pathological criterion. The clusters in
Figures 3A–D show genes whose differential expression was
primarily associated with differentiation. The criterion for this
selection was an inverse gene expression response in the T/DT
experiments compared with the Tg.Ac and D/DT experiments.
The reason was that the differentiation response to TPA was
partially inhibited by DMBA indicated by the decreased
Involucrin (Figure 2M) and Filaggrin (Figure 3B) expression.
Figures 3E–J show gene clusters associated with carcino-
genesis. The primary criterion for selection of these genes
was a similar alteration in expression in the tumor-bearing 9
week Tg.Ac and 14 week D/DT samples. Additionally, it was
decided that the genes selected here should not be differentially
expressed to the same degree in the earlier time point samples,
where tumor formation had not occurred and should not show
an inverse expression in the T/DT sample. This can be seen
particularly for the genes Gsto1, Txn1 and Car2 in cluster E.
We were confident with the association of cluster E with
tumorigenesis as Txn1 overexpression has been shown to
induce papillomas in mice (21). Cluster E shows upregulated
genes as do F and I; though in F the response in the 14 week
D/DT samples is less marked than that in the 9 week Tg.Ac and
in cluster I the converse. Clusters G, H and J show down-
regulated genes. The downregulated genes shown in clusters
H and J were though not equivalent in the 9 week Tg.Ac and 14
week D/DT samples as they were in cluster G. This may have
been due to sample selection or not exact matching of the stage
of tumorigenesis between the two models. Cluster K is differ-
entiated from the others in this group by time. The alterations
in gene expression through the three samples are similar
indicating that these are associated with tumor formation rather
than other pathological changes in the skin. However, the res-
ponses are occurring very early in the time course and decreas-
ing in the tumor-bearing samples (9 week Tg.Ac and 14 week
D/DT). This strongly suggests a differential gene expression in
response to a change in biochemical homeostasis. Many of the
genes in this cluster are ribosomal. It is therefore feasible that
translation is changing in the skin which could be related to the
synthesis of proteins for proliferation, differentiation and
tumor formation. EASE analysis confirmed this hypothesis
(Table I) showing a strong correlation of genes associated
with protein biosynthesis with the proliferation.
RT–PCR confirmation of microarray findings
Genes indicated in red on Figure 3 were representative for a
given cluster and their expression changes confirmed by
RT–PCR. In Figure 4A, RT–PCR verification of differen-
tial gene expression is shown for seven genes from the
differentiation-associated (patterned bars) and carcinogenesis
(solid bars) associated sets. Verification was performed at two
time points, for the FVB/N mouse experiment weeks 2 and 14,
and also week 9 and dissected tumor from the Tg.Ac mice.
Although the time points were selected on the basis of
no papilloma formation; proliferation and differentiation had
occurred during week 2 and papilloma formation during week
14 FVB/N and week 9 Tg.Ac. The tissue used from the
week 14 FVB/N and week 9 Tg.Ac mice contained both papil-
lomas and surrounding skin. Those genes which were assigned
as differentiation-associated Eno3, Cstb, Flg and Cryab
(Figure 4A patterned bars) were differentially expressed
to approximately the same degree in week 2 and the
tumor-bearing skin. In comparison, differential expression
of the tumor-associated genes Txn1, Car2 and Gsto1
(Figure 4A solid bars) was very much greater in the tumor
samples justifying their designation as being more associated
with the tumor formation than proliferation or differentiation.
One gene that was particularly well associated with tumori-
genesis was Gsto1. This gene was therefore chosen for
following through the time course for both the FVB/N
(Figure 4B solid bars) and Tg.Ac experiments (Figure 4B
striped bars). In both FVBN and Tg.Ac, the differential expres-
sion of this gene was much greater in the tumor-bearing sam-
ples (black) compared with the earlier time point samples from
each experiment (grey). For the FVB/N samples TPA-treated
skin was used for comparison to normalize for any effects of
differentiation.
In situ analysis
The location of Gsto1 in the papillomas was determined
using in situ analysis (Figures 5A and B) and compared
with the localization in untreated skin (Figure 5C). Expression
was predominant in the proliferating area of the papillomas. In
the normal skin some expression was detectable in the supra-
basal layers (Figure 5C). At higher power, expression could be
seen it in the upper hair follicles (Figure 5D).
EASE analysis
To discern if there were any particular gene classes that were
significantly associated with the process of proliferation or
differentiation the genes associated in Figure 3 with these
processes were submitted for analysis using EASE (18).
The predominant classes associated with each set of genes
are shown in Table I. The main class of genes associated
with the skin differentiation were members of the myosin
Table I. EASE analysis of the differentiation and proliferation-associated
genes
Gene category EASE score
differentiation
EASE score
proliferation
Muscle contraction 0.004899056 Not found
Morphogenesis 0.007498614 0.999919778
Organogenesis 0.007498614 0.999919778
Development 0.007763048 0.999818149
Muscle fibre 0.012455008 Not found
Energy derivation by oxidation
of organic compounds
0.017112388 Not found
Cell motility 0.029705815 1
Muscle development 0.029705815 1
Myosin 0.044608603 Not found
Structural constituent of muscle 0.056195051 Not found
Protein metabolism 0.056195051 0.000918269
Structural constituent of ribosome Not found 0.002213819
Protein biosynthesis Not found 0.002213819
Ribonucleoprotein complex Not found 0.003698428
Ribosome Not found 0.003698428
Macromolecule biosynthesis 1 0.008999639
Biosynthesis 0.999893738 0.009918753
Cytosolic ribosome (sensu Eukarya) Not found 0.020030629
Nucleic acid binding 0.99896311 0.034868438
RNA binding 0.999478122 0.039342737
This table shows the EASE analysis of the differentiation (upper set)
and proliferation-associated (lower set) of genes. The gene sets
compared were those shown in Figure 3 panels A–D against those in
panels E–K. Bootstrapping was performed with 10 000 iterations and
the sets with an EASE score of less than 0.05 are shown. For clarity
the actual gene annotations in each set have been left out of the table.
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family which are generally associated with muscle deve-
lopment (mybpc2, myh7 (Figure 3A), myh3, myl1 and myl4
(Figure 3C)). For the proliferation-associated genes (Figure 3),
the main gene association was with the classes of genes linked
by a functional association with protein synthesis. As we had
defined these genes as being associated with proliferation,
it was not altogether surprising to find that these were the
main classes of genes overrepresented. Of the three genes
that were particularly characterized, Gsto1 in downstream
analysis has not been previously associated with proliferation
and tumorigenesis in the skin.
Discussion
FVB/N and Tg.Ac mice are established mouse models widely
used to study skin carcinogenesis. This investigation was
undertaken to identify genes whose differential expression
was more closely associated with the pathological phases of
keratinocyte proliferation, differentiation and papilloma
formation. Though association of these cannot be absolute
as tumor tissue is by definition proliferating, it was possible
to identify gene clusters more closely associated with
each pathological phase. In particular, the genes associated
with the tumor formation were more evident. It is theoretically
possible that the differential gene expression observed could be
due to inflammatory infiltrate. However, little inflammation
was observed pathologically or indicated by the differential
gene expression. It seems more likely therefore that the dif-
ferential gene expressions measured here reflect changes in the
keratinocytes. Initiated and promoted FVB/N and promoted
Tg.Ac mice responded as expected to the dosing regimes
employed (Figure 1). The average number of papillomas per
mouse and latency time to first papilloma appearance in the
Tg.Ac mice were comparable with results reported previously
(22). The FVB/N mice in this study showed a comparable
papilloma burden to that reported by Battalora (13) using a
similar treatment schedule (Figure 1). Epidermal proliferation
and differentiation was present in all mice that had been pro-
moted irrespective of initiation and was evident as early as
2 weeks after the start of promotion as has been reported
previously (23) (Figure 2B). However, differentiation was
Fig. 5. In situ hybridization to localize the expression of the gsto1 in the
papillomas. Panels A and B are both papillomas from TPA-treated TgAc
mice. The yellow fluorescence indicates the presence of the gsto1 mRNA
and the nuclei are counterstained in Hoechst 33342. Panels C and D are
from an untreated mouse skin. Inset panels show the no probe negative
controls stained with Hoechst 33342.
Fig. 4. Confirmation of promotion-associated gene expression changes by RT–PCR. The level of gene expression of selected TPA-associated genes in the
mouse samples was confirmed by RT–PCR. (A) For each experimental comparison, the genes more associated with promotion are in the patterned bars, and
those with tumor formation, in the solid bars. In each plot the bars represent the genes as follows (left to right). Differentiation-associated: forward slash;
Eno3, back slash; Cstb, horizontal line; Flg, Cross hatch Cryab. Tumor-associated: light grey; Txn1, dark grey; Car2, black; Gsto1. The mouse strains and
time points are shown in the figure. The comparisons are all against an initiated only control (D) or for Tg.Ac an acetone-treated control. T mice are
promoted only and DT mice, initiated and promoted. Tumors occurred in the DT 14 week sample and Tg.Ac 9 week sample. The Tg.Ac tumor is a dissected
tumor sample. (B) Gsto1 expression through the FVB/N (solid bars) and Tg.Ac (striped bars) time course. FVB/N samples are a ratio of expression in the
DT (tumor forming) samples over T (proliferation) or the Tg.Ac-promoted mouse (T) against the acetone control (A). The final bar is a dissected tumor from
a 9 week Tg.Ac-promoted mouse. Experiments associated where tumor formation has not occurred are in light grey and those samples where tumor
formation has occurred are in black. Ratios are derived from the division of the average of three independent experimental determinations and converted to
log2 for clarity of presentation.
P  0.05; P  0.01 are two-tailed unpaired Student’s t-test results.
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enhanced in TPA-treated skin compared with DMBA- and
TPA-treated skin, and was manifest by the appearance of flat-
tened cells containing prominent keratohyaline granules, and a
marked induction of Involucrin and Filaggrin gene expression
(24). This response was not unexpected as initiated cells are
known to escape differentiation.
Differentiation-associated genes
Those genes identified as being changed in expression in a
manner associated with differentiation were generally altered
at early time points and remained differentially expressed
through to tumorigenesis (Figure 3A–D). The altered exp-
ression of Eno3, Cstb and Flg have previously been recorded
in response to differentiation induced by TPA (12,25–28).
A decrease in Eno3 expression has been demonstrated in
mouse skin 6 h after TPA treatment (12). Eno3 was consist-
ently reduced in expression throughout the time course of this
study, and was classified as a proliferation and differentiation
responsive gene (Figure 3A and 4A). Eno3 is the muscle-
specific form of enolase, associated with glycolysis and inher-
ited recessive metabolic myopathy in humans (29). Therefore,
decreased expression of Eno3 may be associated with its role
in glycolysis, and potentially suggests a reduced requirement
for energy in the differentiating skin. EASE analysis
demonstrated an interesting correlation though of skin differ-
entiation with the expression of muscle-specific genes (Table I)
in particular members of the myosin family and Eno3. There
has been a previous association of myosin expression with
dermatofibromas and it could be that the smooth muscle
proteins are specific markers for differentiating as opposed
to proliferative skin lesions (30).
Table II. Gene annotation for the HUGO annotated genes shown in Figure 3
A. Fstl1 Follistatin-like 1
Gnas Guanine nucleotide binding protein, alpha
stimulating complex locus
Ckm Creatine kinase, muscle
Myh7 Myosin, heavy polypeptide 7, cardiac muscle, beta
Ddt D-dopachrome tautomerase
Aes Amino-terminal enhancer of split
Sara2 SAR1a gene homologue 2 (S. cerevisiae)
M6prbp1 Mannose-6-phosphate receptor binding protein 1
Aco2 Aconitase 2, mitochondrial
Fth1 Ferritin heavy chain 1
Flt1 fms-related tyrosine kinase 1
(vascular endothelial growth factor/vascular
permeability factor receptor)
Gpam Glycerol-3-phosphate acyltransferase, mitochondrial
Apobec2 Apolipoprotein B editing complex 2
Cryab Crystallin, alpha B,
Pmp22 Peripheral myelin protein
Tgfb1 Transforming growth factor
Eno3 Enolase 3, beta muscle
Lgals1 Lectin, galactose binding, soluble 1
Mybpc2 Myosin binding protein C
Des Desmin
Pygm Muscle glycogen phosphorylase
Fasn Fatty acid synthase
Mod1 Malic enzyme, supernatant
Sod1 Superoxide dismutase 1
B. Flg Filaggrin
Csnk2a2 Casein kinase II
Rfc3 Replication factor C (activator 1) 3
Ly6d Lymphocyte antigen 6 complex
C. Atp6v1e1 ATPase, H+ transporting, lysosomal 31kDa,
V1 subunit E isoform 1
Hmgcl 3-Hydroxy-3-methylglutaryl-coenzyme A lyase
Pfkm Phosphofructokinase, muscle
Myh3 Myosin, heavy polypeptide 3
Igfbp5 Insulin-like growth factor binding protein 5
Myl1 Myosin, light polypeptide 1
Myl4 Myosin, light polypeptide 4
Slc25a4 Solute carrier family 25
D. Cstb Cystatin B
Mif Macrophage migration inhibitory factor
Npm1 Nucleophosmin
Idb4 Inhibitor of DNA binding 4
E. Car2 Carbonic anhydrase 2
Arg1 Arginase
Txn1 Thioredoxin
Gsta3 Glutathione S-transferase, alpha 3
Gsto1 Glutathione S-transferase omega 1
Serpina1a Cell division cycle 2 homologue A
Sprr1b Small proline-rich protein 1B (cornifin)
Slc19a1 Solute carrier family 19 (folate transporter), member 1
Tpp2 Tripeptidyl peptidase II
Ppargc1a Peroxisome proliferative activated receptor
Tgfa Transforming growth factor alpha
F. Hnrpab Heterogeneous nuclear ribonucleoprotein A/B
Krt2 Keratin
G. Fancc Fanconi anaemia, complementation group C
Cox7b Cytochrome c oxidase subunit VIIb
Atp5k ATP synthase, H+ transporting,
mitochondrial F1F0 complex, subunit e
Cox7c Cytochrome c oxidase, subunit VIIc
Sh3kbp1 SH3-domain kinase binding protein 1
Lcp2 Lymphocyte cytosolic protein 2
Fcgr2b Fc receptor, IgG
Cox17 COX17 homologue, cytochrome c oxidase assembly protein
Gjb1 Gap junction membrane channel protein beta 1
S100a10 S100 calcium binding protein A10 (calpactin)
Ltbp3 Latent transforming growth factor beta binding protein 3
Ddah1 Dimethylarginine dimethylaminohydrolase 1
Xrcc5 X-ray repair complementing defective
repair in Chinese hamster cells 5
Igh AT rich interactive domain 3A
Table II. Continued
H. C3 Complement component 3
Itm2a Integral membrane protein 2A
Fgr Gardner-Rasheed feline sarcoma viral oncogene homologue
H19 H19 fetal liver mRNA
Vdac1 Voltage-dependent anion channel 1
I. Got2 Glutamate oxaloacetate transaminase 2, mitochondrial
Hba Haemoglobin alpha chain
J. Anxa5 Annexin A5
Gnai2 Guanine nucleotide binding protein, alpha inhibiting 2
Alas2 Aminolevulinic acid synthase 2, erythroid
Pctk1 PCTAIRE-motif protein kinase 1
Atp5j ATP synthase, H+ transporting, mitochondrial F0 complex
Polr2b Polymerase (RNA) II (DNA directed) polypeptide B
Ccl6 Chemokine (C-C motif) ligand 6
Gpx3 Glutathione peroxidase 3
Ifi203 Interferon inducible protein 203
Thbs2 Thrombospondin 2
K. Rps11 Ribosomal protein S11
Gtf2b General transcription factor IIB
Rps3 Ribosomal protein S3
Rps9 Ribosomal protein S9,
Rplp2 Ribosomal protein, large P2
Cd3g CD3 antigen, gamma polypeptide,
Rpl11 Ribosomal protein L11
Rpl9 Ribosomal protein L9
Rpl5 Ribosomal protein L5
Rps3a Ribosomal protein S3a
Rps26 Ribosomal protein S26
For clarity only the HUGO gene symbols have been shown in Figure 3.
The complete gene name is given here in the same order as Figure 3.
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Both Cstb and Flg are associated with keratinocyte differ-
entiation and found in the cornified envelope (25–28). Com-
mensurate with this Flg is also known to be increased during
calcium-induced differentiation of skin cells (26,28) and in
response to TPA and v-ras transfection. Homologues of
Cstb have been demonstrated to be crosslinked to Flg by trans-
glutaminase, a process that occurs in cornified envelope forma-
tion. Cstb homologues are also elevated in expression during
wound healing (11,31). Thus, the alteration in expression of
these two genes with differentiation and proliferation as seen
in this study is entirely consistent with the known functional
roles for these genes in skin. Reduced expression of the chap-
erone protein Cryab was consistent in both strains of mice
across the time course studied (Figure 3A and 4A). The eleva-
tion of Cryab expression has been associated with resistance to
the effects of DNA-damaging drugs (32), and reduced Cryab
expression in epithelial ovarian cancer correlates with reduced
median survival time (33).
Tumor and proliferation-associated genes
Tumor and proliferation-associated genes were primarily
defined by their differential expression in the tumor-bearing
skin samples and are shown in Figure 3 (E–K). EASE analysis
of this gene set (Table I) primarily identified genes associated
with protein synthesis. Given that these genes had been selec-
ted on the basis of their differential expression in tumor-
bearing samples; this is perhaps not a surprising association.
For further analysis we chose three genes whose differential
expression was strongly associated with tumor formation, but
were not included in the EASE analysis of genes associated
with protein synthesis. Increased expression of the tumor-
associated gene Txn1 was small (Figure 3E) when assessed
by microarray analysis. We chose to investigate this gene
further because of its known cancer association. Using
RT–PCR we further corroborated significant changes in the
expression of Txn1 in 9 weeks promoted Tg.Ac skin. DMBA
and TPA have previously been demonstrated to increase the
activity of Txn1 (34). Thus, it may be that Txn1 induction is
partly modulated by both proliferation/differentiation and
cancer-associated mechanisms. Txn1 was elevated in the
three samples containing papillomas that were analysed by
RT–PCR (Figure 4A). There are conflicting reports on the
effect of Txn1 expression on cell growth. Recombinant Txn
enhances the growth of NIH3T3 cells, whereas in HeLa, Txn1
is required for interferon g-mediated growth inhibition (35,36).
In mice, a 2-fold overexpression of Txn1 leads to an increase
in papilloma formation with the DT protocol (21). Immunos-
taining has shown Txn1 in differentiated squamous cell car-
cinomas (37) and expression has been found to be increased in
gastric carcinomas (38).
Car2 and Gsto1 gene expression was markedly increased in
expression during the course of these studies, as demonstrated
both by microarray analysis and RT–PCR. The mRNA levels
of Car2 were altered in both a promotion-dependent (early
time points) and a skin papilloma-associated manner. The pos-
sibility of a Car2 role in skin cell differentiation in response to
TPA promotion is appealing as Car2 is present in differentiated
osteoclasts. It is induced by differentiation stimuli and inhib-
ited when terminal differentiation is abrogated (39–41).
However, here the changes in Car2 levels were associated
with papilloma formation (Figure 4A), and therefore the con-
trol stimuli may be different. Strongly associated with the
formation of the skin tumors was increased expression of
Gsto1 (Figures 3E, 4A and B). In situ analysis clearly showed
the expression of this gene within the proliferative areas of the
papillomas (Figure 5A and B). Although Gsto1 is classified as
a Gst, this isoform not only has weak Gst activity, but also
possesses other thiol transferase (42) and dehydroascorbate
reductase (43) activities more widely associated with
glutaredoxins. Dehydroascorbate reductase activity may be
pertinent to the skin as several in vitro studies have shown
that ascorbate or its stable derivative AA-2P cause keratinocyte
cell differentiation, protect against UV-induced cell damage
and enhance production of lipids associated with the cornified
envelope (44–46). In a survey of human tissues, Gsto1
was only found expressed within the macrophages of the
skin (47). However, it is unlikely that macrophages are
solely responsible for the Gsto1 detected within the skin in
this study, as we did not see an inflammatory infiltrate either
within papillomas or hyperplastic skin. Gstpi, another member
of the GST family has been shown to function as a tumor
suppressor in skin carcinogenesis experiments and Gstpi
null mice show enhanced sensitivity to chemically induced
skin tumorigenesis (48). We did not see increased expression
of Gstpi, though there was an increased expression of
Gsta1, which showed a similar expression profile to that of
Gsto1.
Generally increased in expression through the time course to
tumor formation in all comparisons were members of the ribo-
somal family such as Rpl11. The increased expression of these
genes would indicate a general increase in translation and
protein synthesis. These genes were primary contributors to
the EASE identification of gene classes associated with protein
synthesis (Table I). Previously there have been reports of
increased translation in response to TPA, e.g. of the elongation
factors, and this would not be unexpected; given the prolifera-
tion response and the increased need for protein (49).
In summary, this work has identified some genes differen-
tially expressed and associated with the general effects of
tumor promotion and differentiation in the skin, and others
more closely associated with papilloma formation in FVB/N
and Tg.Ac mice. Some of these were altered prior to the
formation of papillomas and were associated with papilloma
formation. The association of Gsto1, Cryab and Car2 with
tumor formation suggests a potentially fundamental role for
these proteins in the process of tumor formation and develop-
ment.
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